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Introduction
Being a gynecological emergency (1,2), the 
torsion of the ovary is a partial or complete 
rotation of the ovary, the fallopian tube or both of 
them around their vascular axis (3). Of the total 
torsional cases, 70-80% occur in women of re-
productive age (4). The incidence is 4.9/100000 
in women under the age of 20 (1,5,6,7,8), but it 
may affect women at any age (9,10).
The first choice in the treatment is to detorsion 
the torsioned anexa, but it is well known that 
reperfusion can increase the initial ischemic 
injuries because it determines reactive oxygen 
species (ROS) production (11) leading to a high 
level of oxidative stress and reperfusion lesions. 
Reperfusion injury describes the events associ-
ated with restoration of blood flow that did not 
occur during the ischemia period and can be pre-
vented by an intervention given only at the mo-
ment of reperfusion (12).
IMA is a biomarker of oxidative stress in hypox-
ic conditions (13). High levels of IMA are de-
tected in diseases associated with ischemic pro-
cesses (14,15) due to modification of the serum 
albumin N-terminal end (16,17,18). Increase of 
IMA in ovarian torsion was shown in different 
studies (2,9,10,19). In the acute ischemia IMA 
is a product of ROS interaction with the protein 
albumin (20). 
The N-terminal end of albumin has a sequence 
aspartate-alanine-histidine-lysine that is respon-
sible for Co2+ binding (17). Hydroxyl radical 
interaction with the N-terminal end of albumin 
determines the changes that release the Co2+ (21). 
ROS derived from a torsioned ovary are involved 
in the reduction of albumin capacity to bind 
transition metals. This leads to the formation of 
a new variant of albumin known as IMA (10). 
It is a nonspecific marker for ischemia because 
ROS can be formed in every kind of ischemia 
(9). ROS production increases in the reperfusion 
period, thus we suppose that the technique of 
reperfusion is important to prevent the growth of 
ischemic lesions. 
There are no studies in the literature that exam-
ine the IMA in serum and ovarian homogenates 
in different types of reperfusion for ovarian tor-
sion. The relationship between controlled reper-
fusion and IMA levels in the ovarian torsion was 
not studied before.
The aim of our research was to investigate the 
effect of different ovarian torsion/detorsion 
models on serum and ovarian homogenates IMA 
levels and to appreciate the effectiveness of the 
controlled reperfusion method in reducing the 
reperfusion injuries.
Material and methods
Seventy healthy female rats (Rattus	 albicans), 
weighing 180-265 grams, were taken from the 
Nicolae Testemitanu State University of Medi-
cine and Pharmacy vivarium. All manipulations 
were made in the Laboratory of Biochemis-
try of Nicolae Testemitanu State University of 
Medicine and Pharmacy. The animals were used 
and maintained in accordance with the Animal 
Welfare Act. The Research Ethics Committee of 
Nicolae Testemitanu State University of Medi-
cine and Pharmacy, Republic of Moldova, ap-
proved our study protocol (08.02.2016).
The rats were randomly divided into seven ex-
perimental groups (n=10): group 1: control (no 
intervention); group 2: sham (only laparotomy); 
group 3: ischemia (ovarian torsion for 3 hours); 
group 4: ischemia (ovarian torsion for 3 hours) 
and 1 hour simple reperfusion; group 5: isch-
emia (ovarian torsion for 3 hours) and 1 hour 
controlled reperfusion; group 6: ischemia (ovari-
an torsion for 3 hours) and 24 hours simple reper-
fusion; group 7: ischemia (ovarian torsion for 3 
hours) and 24 hours controlled reperfusion.
Surgical procedures were done under sterile con-
ditions and anesthesia. The animals were anes-
thetized with 10% ketamine hydrochloride sol., 
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50 mg/kg (Calypsol®, Gedeon Richter, Hunga-
ry) administered intraperitoneally. The time was 
considered appropriate for surgical intervention 
when the animals remained motionless in a su-
pine position. The abdominal skin was shaved 
and disinfected with Iodine povidone 100 mg/ml 
(Betadine®, Egis Pharmaceuticals PLC, Hun-
gary). The animals breathed spontaneously and 
were positioned in dorsal decubitus. The inter-
vention time was approximately 15 minutes. A 
2-2.5 cm laparatomy was performed - a vertical 
incision in the lower abdomen. The rats from 
group 1 (control) were anesthetized, the ova-
ries were removed and blood collected from the 
abdominal aorta, after which the animals were 
euthanized. The rats from group 2 (sham) were 
anesthetized, laparatomy was performed and af-
ter 15 minutes the abdominal wall was closed 
by applying 3/0 silk sutures. After 3 hours the 
animals were anesthetized, re-laparatomy was 
performed, the ovaries were removed and blood 
from the abdominal aorta colected, after which 
the animals were euthanized.
In groups 3, 4, 5, 6 and 7 the ovarian torsion was 
induced by twisting the annexes three times in 
clockwise direction. After twisting, the annex-
es were fixed to the abdominal wall by apply-
ing 3/0 silk suture and then the abdominal wall 
was closed by applying 3/0 silk sutures. After 
3 hours of torsion the rats were anesthetized, 
re-laparatomy was performed and according to 
the group they belong, the ovaries were removed 
and blood collected from the abdominal aorta 
for group 3, or simple detorsion (simple reper-
fusion) was performed for 1 hour for group 4, 
and  24 hours for group 6, or controlled detorsion 
(controlled reperfusion) for 1 hour for group 5, 
and 24 hours for group 7. The controlled reper-
fusion was performed by opening and closing 
the clips that were applied on the ovarian annex-
es (on/off) in 10-seconds intervals for the first 2 
minutes of reperfusion. The abdominal wall was 
closed by applying 3/0 silk sutures. At the end 
of the reperfusion period the animals were anes-
thetized, re-laparatomy was performed with the 
removal of the ovaries and blood samples colec-
tion from the abdominal aorta, after which the 
animals were euthanized.
The blood samples were placed into tubes allow-
ing to clot for 30 minutes, then centrifuged 10 
minutes at 3000 rpm. Serum was stored at -40º 
C until analysis.
The ovarian tissue (0,2 g) was  homogenized 
in ice with 2 ml of phosphate  buffer 0.1 M 
(pH=7.4), centrifuged at 4ºC, 3000 rpm for 15 
minutes. The supernatant stored at -40º C until 
analysis.
The IMA levels were determined in blood serum 
and ovarian homogenates samples according to 
the modified cobalt-binding assay described by 
Gudumac V. and Tagadiuc O. (22). 
The obtained data were analysed using SPSS 20.0 
software. Descriptive statistical methods (mean, 
standard error of the mean) were used. Nor-
mality tests were done using the Kolmogorov- 
Smirnov and Shapiro-Wilk tests. The homo-
geneity of variance was tested using Levene’s 
test. The comparisons between groups were per-
formed using Welch’s	ANOVA with Games-How-
ell post hoc test. Correlation analysis was done 
using Spearman correlation test. A p < 0.05 val-
ue was considered statistically significant.
Results
There is a statistically significant increase of 
IMA levels in serum in the sham group compared 
to control group, from 402.370 ± 2.732 µmol/L 
to 418.472 ± 1.854 µmol/L (p=0.003) (figure 1). 
Ischemia (group 3) determined IMA increase up 
to 478.359 ± 5.218 µmol/L compared to control 
and sham groups (p<0.001). Statistically sig-
nificant high levels of IMA were registered at 
1 hour (490.024 ± 3.376 µmol/L) and 24 hours 
(483.370 ± 1.550 µmol/L) of simple reperfusion 
compared to 1 hour (452.564 ± 3.096 µmol/L, 
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p<0.001) and 24 hours (454.207 ± 0.878 µmol/L, 
p<0.001) of controlled reperfusion.
In the ovarian homogenates (figure 2) the IMA 
values were 14.233 ± 0.458 µmol/g.prot. in the 
control group, 14.251 ± 0.733 µmol/g.prot. in the 
sham group, 15.274 ± 0.284 µmol/g.prot. in the 
ovarian torsion (ischemia) group, 17.384 ± 1.018 
µmol/g.prot. in the ovarian torsion/1 hour sim-
ple reperfusion group, 16.423 ± 1.618 µmol/g.
prot. in the ovarian torsion/1 hour controlled 
reperfusion group, 16.855 ± 1.211 µmol/g.prot. 
in the ovarian torsion/24 hours simple reperfu-
sion group, 16.106 ± 1.154 µmol/g.prot. in the 
ovarian torsion/24 hours controlled reperfusion 
group. There were no statistically significant dif-
ferences between groups (p>0.05).
No correlations were found between the serum 
IMA levels and the one registered in ovarian ho-
mogenates.
Discussion
Diseases characterized by acute ischemia are 
considered medical emergencies and the main 
treatment tactic involves the restoration of the 
tissue blood flow to prevent the necrosis. How-
ever, after an ischemic period, reperfusion can 
increase the initial ischemic injuries due to ROS 
Fig1. IMA values in serum
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production. ROS can change different mole-
cules, one of them being the protein albumin 
found in the blood. The changes in the structure 
of this protein lead to the formation of IMA. So, 
the new protein that originates from albumin is 
produced during the ischemic period and in the 
reperfusion phase it is possible to increase its 
amounts because of an intensive oxidative stress. 
It is well known that the amounts of IMA be-
gin to rise within minutes following an ischemic 
process (14,15).
The concept of controlled reperfusion was ap-
plied by different researchers in different pa-
thologies including the torsion of the ovaries. 
In the experimental study done by Ingec M. et 
al. where a similar method of reperfusion for 
ovarian torsion was used as was for our study, 
the damage markers related to oxidative stress 
(malondialdehyde and 8-hydroxyguanine) were 
found to be lower in the controlled reperfusion 
group (23). The Ozkisacik S. et al. research with 
a different study design for ischemia/reperfusion 
injury in ovarian torsion concluded that gradual 
detorsion can reduce the reperfusion injury (24).
As in our study, the Aran T. et al. experiment has 
shown that ovarian torsion increases significant-
ly the serum IMA levels compared to the control 
group (9). Another research conducted by Yildi-
rim A. et al. has found higher serum IMA in the 
ovarian torsion group compared to control and 
Fig2. IMA values in ovarian homogenates.
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also a strong correlation with the histopathologic 
changes (19).
Contrary to our findings and the studies done by 
Aran T. et al. and Yildirim A. et al., the research 
of Karatas Gurgun A. et al. did not find significant 
increase in the IMA levels in the torsion groups 
suggesting that IMA may gain more significance 
with increasing duration of ischemia (2).
In our research, IMA levels registered in ho-
mogenates were not significantly different, but 
there is a tendency for them to increase after the 
torsion of the ovary with approximately 7.3% 
compared to the control group. The amount of 
IMA registered at 1 hour of simple reperfusion 
after detorsion was by 22.1% higher than those 
recorded in the control group. This fact confirms 
once again that ischemia activates the processes 
responsible for albumin modification, decreas-
ing its capacity to bind Co2+. Simple reperfusion 
increasing the oxidative stress stimulates the 
IMA formation, confirming the protein changes 
after restoration of blood flow. 
As was shown in other studies with ischemia 
and reperfusion, ischemia is dangerous, but 
reperfusion can be worse (25). The same thing 
is confirmed by our results. The simple reperfu-
sion groups had higher IMA levels compared to 
ischemia group in both serum and ovarian ho-
mogenates. However, the controlled reperfusion 
groups had a statistically significant low IMA in 
serum compared to simple reperfusion groups. 
IMA was found to be higher in the ovarian ho-
mogenates of simple reperfusion compared to 
controlled reperfusion groups also. Therefore, 
the type of reperfusion can influence the IMA 
production.
The lack of correlation between serum IMA and 
homogenate IMA suggests the need for careful 
interpretation of the increase of this biomarker 
in the blood, and that it should always be viewed 
in a clinical context.
There is one clinical study investigating  the 
amounts of IMA in patients with pelvic pain, in-
dicating that elevated serum concentrations and 
clinical suspicion of ovarian torsion is a situation 
when doctors can decide to do a laparoscopy to 
exclude the torsion (10).
Conclusion
Ischemia and reperfusion can increase protein 
changes and the IMA level in experimental 
ovarian torsion. Controlled reperfusion  reduces 
the protein damage, registered by a decreased 
level of IMA in blood serum samples of con-
trolled reperfusion groups. Decreased levels of 
IMA in controlled reperfusion groups indicate 
that this type of reperfusion is able to protect 
the organ from ROS production and to minimize 
the reperfusion injury in  experimental ovarian 
torsion. The IMA should be examined in clinical 
context.
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